We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

ROCHE DIAGNOSTICS CORP

Roche Diagnostics Corporation is the North American headquarters of Roche Diagnostics, a global leader in diagnostics... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Automated Extraction of FFPE Tissue for High-Risk HPV Testing

By LabMedica International staff writers
Posted on 07 Jul 2016
Print article
Image: The automated cobas 4800 platform system (Photo courtesy of Roche).
Image: The automated cobas 4800 platform system (Photo courtesy of Roche).
The testing for high-risk human papillomavirus (HR-HPV) in head and neck squamous cell carcinomas is important for both prognostication and clinical management. Several testing platforms are available for HR-HPV; however, effective alternative automated approaches are needed.

High-risk human papillomavirus (HR-HPV) is now a well-established etiologic agent in a subset of head and neck squamous cell carcinomas (HNSCCs) that has an incidence on the rise, particularly with respect to oropharyngeal squamous cell carcinoma (OPSCC), which demonstrates an association with transcriptionally active virus in up to 80% of tumors.

Pathologists from Massachusetts General Hospital (Boston, MA, USA) collected from 62 archival specimens of formalin-fixed, paraffin-embedded (FFPE) samples of HNSCC. Overall OPSCC represented slightly more than half (55%) of the HNSCCs tested. These were prepared using the automated system by deparaffinization and dehydration followed by tissue lysis. Corresponding FFPE samples were evaluated for HR-HPV by in situ hybridization (ISH) and p16 by immunohistochemistry. Discrepant cases were adjudicated by polymerase chain reaction (PCR).

The scientists used the automated Roche cobas 4800 System Platform (Roche Diagnostics, Risch-Rotkreuz, Switzerland), which consists of an automated instrument for sample preparation and DNA extraction followed by and coupled to a thermocycler and analyzer for performance of real-time PCR and subsequent detection of target DNA sequences. Immunohistochemical expression of p16 was evaluated by deparaffinizing 5µm FFPE sections of HNSCCs and performing antigen retrieval using the Leica Bond protocol (Leica Biosystems, Buffalo Grove, IL, USA).

The investigators found 32/62 (52%) of formalin-fixed, paraffin-embedded tumors were positive for HR-HPV by cobas. There were 28/32 (88%) of cases were the HPV 16 subtype and 12% (4 /32) were other HR-HPV subtypes. Corresponding testing with ISH was concordant in 92% (57 /62). Compared with the adjudication PCR standard, there were three false-positive cases by cobas. For the OPSCC, cobas had positive and negative predictive values of 100%, whereas for non-OPSCC, the positive predictive value was 57% and the negative predictive value was 100%.

The authors concluded that concordance in HNSCC HR-HPV status between cobas and ISH was more than 90%. The cobas demonstrated a sensitivity of 100% and a specificity of 91% for detection of HR-HPV. They said the advantages favoring cobas included its automation, cost efficiency, objective results, and ease of performance. The study was published in an early online edition of the journal Archives of Pathology & Laboratory Medicine.

Related Links:
Massachusetts General Hospital
Roche Diagnostics
Leica Biosystems
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.